Literature DB >> 4206525

The trypanocidal action of human serum and of baboon plasma.

F Hawking, D B Ramsden, S Whytock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4206525     DOI： 10.1016/0035-9203(73)90081-3

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  7 in total

1.  In vitro generation of human high-density-lipoprotein-resistant Trypanosoma brucei brucei.

Authors:  Sara D Faulkner; Monika W Oli; Rudo Kieft; Laura Cotlin; Justin Widener; April Shiflett; Michael J Cipriano; Sarah E Pacocha; Shanda R Birkeland; Stephen L Hajduk; Andrew G McArthur
Journal:  Eukaryot Cell       Date:  2006-08

Review 2.  Similarities of lipid metabolism in mammalian and protozoan cells: an evolutionary hypothesis for the prevalence of atheroma.

Authors:  W E Ormerod; S Venkatesan
Journal:  Microbiol Rev       Date:  1982-09

3.  Characterization of a novel trypanosome lytic factor from human serum.

Authors:  J Raper; R Fung; J Ghiso; V Nussenzweig; S Tomlinson
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  Identification of haptoglobin as a natural inhibitor of trypanocidal activity in human serum.

Authors:  A B Smith; S L Hajduk
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

Review 5.  The Difference Between High Density Lipoprotein Subfractions and Subspecies: an Evolving Model in Cardiovascular Disease and Diabetes.

Authors:  W Sean Davidson; Allison L Cooke; Debi K Swertfeger; Amy S Shah
Journal:  Curr Atheroscler Rep       Date:  2021-03-27       Impact factor: 5.113

6.  Hemoglobin is a co-factor of human trypanosome lytic factor.

Authors:  Justin Widener; Marianne Jensby Nielsen; April Shiflett; Søren Kragh Moestrup; Stephen Hajduk
Journal:  PLoS Pathog       Date:  2007-09-28       Impact factor: 6.823

7.  The main lytic factor of Trypanosoma brucei brucei in normal human serum is not high density lipoprotein.

Authors:  J Raper; V Nussenzweig; S Tomlinson
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.